dr. long on rationale for nivolumab/ipilimumab in patients with melanoma who have brain mets
Published 4 years ago • 228 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
0:48
dr. long on including patients with melanoma who have brain mets on clinical trials
-
1:17
dr. long on sequencing local therapy in patients with melanoma who have brain mets
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
2:45
long-term outcomes of nivo vs. nivo/ipi in melanoma brain metastases: abc trial data
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
7:08
the value of ipi/nivo in treating metastatic melanoma
-
9:06
implications of new nivolumab and ipililumab combination data in melanoma brain metastases
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
7:28
new data for immunotherapy in melanoma brain metastases
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs